Krebs Biochemicals & Industries Limited (NSE:KREBSBIO)
India flag India · Delayed Price · Currency is INR
59.80
+0.31 (0.52%)
Feb 19, 2026, 3:29 PM IST

NSE:KREBSBIO Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Market Capitalization
1,2421,4401,3161,2163,0921,743
Market Cap Growth
-46.56%9.46%8.19%-60.67%77.35%18.25%
Enterprise Value
3,4553,4843,1932,9524,3192,560
Last Close Price
59.4966.3761.4556.50143.0585.95
PS Ratio
5.403.332.612.335.183.31
PB Ratio
-0.77-0.98-1.10-1.22-4.12-4.08
P/OCF Ratio
--55.63---
EV/Sales Ratio
15.018.056.335.667.234.86
Debt / Equity Ratio
-1.38-1.45-1.62-1.84-1.91-2.60
Net Debt / Equity Ratio
-1.38-1.45-1.62-1.84-1.90-2.58
Net Debt / EBITDA Ratio
-22.38-14.34-22.47-11.85-4.23-6.39
Net Debt / FCF Ratio
--18.51-27.45-4.60-3.23-2.75
Asset Turnover
-0.250.290.290.340.36
Inventory Turnover
-1.190.831.452.063.20
Quick Ratio
0.000.000.080.020.010.02
Current Ratio
0.090.100.280.330.460.44
Return on Assets (ROA)
--7.66%-5.38%-7.49%-14.14%-9.45%
Return on Capital Employed (ROCE)
-30.10%-32.50%-13.10%-17.40%-35.30%-20.00%
Earnings Yield
-18.41%-18.71%-14.99%-20.31%-14.40%-16.27%
FCF Yield
--7.95%-5.36%-32.79%-14.33%-22.99%
Buyback Yield / Dilution
0.03%----9.89%-9.00%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.